@article{0be435cc0fb6498d95ccd64cb5d1dff1,
title = "An empirical validation of neuropsychiatric symptoms and agitation profiles in dementia using data from an online symptom tracking tool",
author = "Kenneth Rockwood and Justin Stanley and Lisa Mcgarrigle",
note = "Funding Information: In addition to academic and hospital appointments, KR is president and chief science officer of DGI Clinical, which in the last 5 years had contracts with pharma and device manufacturers (Baxter, Baxalta, Biogen, Shire, Hollister, Nutricia, Roche, and Otsuka) on individualized outcome measurement. In 2017, he attended an advisory board meeting with Lundbeck. Otherwise, any personal fees are for invited guest lectures, rounds and academic symposia, received directly from event organizers, for presentations on frailty. He is the associate director of the Canadian Consortium on Neurodegeneration in Aging, which is funded by the Canadian Institutes of Health Research (CNA-137794), with additional funding from the Alzheimer Society of Canada and several other charities, as well as from Pfizer Canada and Sanofi Canada (in phase 1, 2014-2019). He receives career support from the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer Research and research support through grants from the Canadian Institutes of Health Research, the Canadian Frailty Network, the Nova Scotia Health Research Foundation, the Nova Scotia Health Authority Research Fund, and the Fountain Family Innovation Fund of the QEII Health Science Centre Foundation. JS and LM are employees of DGI Clinical Inc.",
year = "2020",
month = apr,
day = "1",
doi = "10.1017/S1041610219001406",
language = "English",
volume = "32",
pages = "533--534",
journal = "International Psychogeriatrics",
issn = "1041-6102",
publisher = "Cambridge University Press",
number = "4",
}
